Efficacy and safety of MAS825 (anti-IL-1/IL-18) in COVID-19 patients with pneumonia and impaired respiratory function

Alex D. Hakim, Mustafa Awili,Hollis R. O'Neal, Omar Siddiqi,Naseem Jaffrani,Richard Lee,Jeffrey S. Overcash,Ann Chauffe,Terese C. Hammond,Bela Patel,Michael Waters,Gerard J. Criner,Alok Pachori,Guido Junge,Rafael Levitch, Jen Watts, Philip Koo,Tirtha Sengupta, Lili Yu,Michael Kiffe, Anne Pinck, Richard R. Stein, Jamie Bendrick-Peart, Janet Jenkins, Marianna Rowlands,Frank Waldron-Lynch, Jesse Matthews

CLINICAL AND EXPERIMENTAL IMMUNOLOGY（2023）

Cited 0|Views2
No score
Key words
MAS825,COVID-19,pneumonia,impaired respiratory function,efficacy and safety
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined